Infinium Global Research Collagen Peptide Market | страница 2

A latest report has been added to the wide database of Collagen Peptide Market by Infinium Global Research.
This report studies the Collagen Peptide Market by source type (bovine collagen peptide, porcine collagen
peptide, chicken collagen peptide, fish collagen peptide), application (bone and joint health, nutraceuticals,
cosmeceuticals, food and beverage, pharmaceuticals) market status and outlook of global and major regions,
from manufacturers, and end industries. The objective of the study is to identify market sizes of different
segments & countries in recent years and to forecast the values for the next six years. Collagen Peptide
Market provides opportunities in micro markets for stakeholders to invest along with the detailed analysis of
competitive landscape, latest trends, and product offerings of the major companies in the Collagen Peptide
Market. According to the report the Global Collagen Peptide Market is projected to grow at a CAGR of 10.1%
in terms of value over the period of 2017-2023. The growth in the world market is primarily driven by
significant contribution by North America (Leading region) region to this market. Collagen peptide is a natural
body protein inside the body. It is produced in the body to prevent dermal layers of the skin from developing
skin folds. Collagen peptide is made from collagen through an enzymatic hydrolysis process and which is why it
is often referred to as hydrolyzed collagen. Collagen peptides are rich source of protein and healthy nutrition.
They improve health of bones, and are effective for beautiful skin. Collagen peptide is used as cosmetic or
medical collagen in different skin creams and treatments to reduce the appearance of wrinkles and to
moisturize skin.
Market Insights
Increasing consciousness about wellbeing and wrinkle free skin in old-age and increasing awareness pertaining
to the benefits of collagen peptide products about personal healthcare are expected to be the key driving
growth factors. Further, increasing R&D activities for the development of novel drug formulations and
favorable regulations for regenerative medicine application are anticipated to bring more opportunities for
the major players in the market.